Outcome of Board Meeting for raising of fund by way of issue of equity shares held on November 03, 2026
As filed · Camlin Fine Sciences Limited has informed the Exchange regarding Outcome of Board Meeting for raising of fund by way of issue of equity shares held on November 03, 2026.
What happened
FactOutcome of Board Meeting for raising of fund by way of issue of equity shares held on November 03, 2026. Raising of fund by way of issue of equity shares of the Company of face value ₹ 1 each through. but not limited to issue price, rights entitlement ratio, record date, timing and terms of payment.
Why it matters
CapitSignal interpretationRaising capital changes the share count or the debt load, and the stated use of proceeds is a commitment that can later be checked.
What management said before
Prior statements by this company that CapitSignal has recorded changing.
Margins
DelayedWe feel that in this quarter, the second quarter itself, we will have a positive EBITDA in Aroma.
We feel that now the margin should be in the range of 10% to 12% this year.
Change
FactImplication
CapitSignal interpretationWatch next
Fact- Instrument and amount finally raised
- Stated use of proceeds
- Whether the enabling resolution is actually used
- To answer your question on next year, FY'27, the gross margin should improve by at least a couple of percent w (management committed by FY27)
- For FY'27, we have both methyl Vanillin and ethyl Vanillin and our guidance for FY'27 is between the two, the (management committed by FY27)
Evidence
- Camlin Fine Sciences Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026.(opens the original filing in a new tab)
- Earlier statement · Q1 FY27
- Latest statement · Q1 FY27
- Earlier statement · Q1 FY27
How CapitSignal classified this
- Reasoning:
- FUNDRAISE base 58; +5 quantified amount; matched on subject
- Matched on:
- the filing's own subject line
- Confidence in the event type:
- 75%